Log in to save to my catalogue

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activat...

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31256161

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome

About this item

Full title

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome

Publisher

Basel, Switzerland: S. Karger AG

Journal title

International archives of allergy and immunology, 2019-01, Vol.180 (1), p.44-51

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Mast cell activation syndrome (MCAS) is a condition characterized by recurrent episodes of clinically relevant, systemic, severe reactions to mast cell (MC)-derived mediators released in the context of anaphylaxis or another acute MC-related event. It is important to document MC involvement in these reactions in order to establish the diagnosis MCA...

Alternative Titles

Full title

Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_31256161

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_31256161

Other Identifiers

ISSN

1018-2438

E-ISSN

1423-0097

DOI

10.1159/000501079

How to access this item